Propanc Biopharma, Inc. (OTCMKTS:PPCB) Short Interest Up 100.0% in March

Propanc Biopharma, Inc. (OTCMKTS:PPCB) saw a large growth in short interest during the month of March. As of March 15th, there was short interest totalling 200 shares, a growth of 100.0% from the February 28th total of 100 shares. Based on an average daily volume of 400 shares, the short-interest ratio is currently 0.5 days. Approximately 0.0% of the shares of the company are short sold.

Propanc Biopharma Stock Performance

Shares of OTCMKTS PPCB traded down $0.43 during trading hours on Friday, reaching $5.25. The stock had a trading volume of 116 shares, compared to its average volume of 415. Propanc Biopharma has a twelve month low of $2.76 and a twelve month high of $222.00. The business’s fifty day moving average is $6.64 and its two-hundred day moving average is $2.32.

About Propanc Biopharma

Propanc Biopharma, Inc, a biopharmaceutical company, develops cancer treatments for patients with pancreatic, ovarian, and colorectal cancer in Australia. It offers PRP, a formulation lead product that is in preclinical phase of development designed to enhance the anti-cancer effects of multiple enzymes.